Muthusamy Shanmugam
Chief Tech/Sci/R&D Officer at ANI PHARMACEUTICALS, INC.
Net worth: 59 M $ as of 30/03/2024
Profile
Mr. Muthusamy Shanmugam is a Director & Head-Research & Development at ANI Pharmaceuticals, Inc. and a Chief Operating Officer, Director & Head-R&D at Novitium Pharma LLC.
He is on the Board of Directors at ANI Pharmaceuticals, Inc., Nuray Chemicals Pvt Ltd., Novitium Pharma LLC and Saimirra Innopharm Pvt Ltd.
He received his graduate degree from The Tamil Nadu Dr. M.G.R.
Medical University and a graduate degree from JSS College of Pharmacy.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/04/2024 | 856,272 ( 4.06% ) | 59 M $ | 30/03/2024 |
Muthusamy Shanmugam active positions
| Companies | Position | Start |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/11/2021 |
Nuray Chemicals Pvt Ltd.
 Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Director/Board Member | 19/07/2016 |
Novitium Pharma LLC
 Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Founder | 31/12/2015 |
Saimirra Innopharm Pvt Ltd.
 Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Director/Board Member | 21/10/2012 |
Training of Muthusamy Shanmugam
| The Tamil Nadu Dr. M.G.R. Medical University | Graduate Degree |
| JSS College of Pharmacy | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Nuray Chemicals Pvt Ltd.
Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Health Technology |
Novitium Pharma LLC
Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Health Technology |
Saimirra Innopharm Pvt Ltd.
Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Health Technology |
- Stock Market
- Insiders
- Muthusamy Shanmugam
